Slowly going OT: BE study simulations [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2016-02-13 16:02 (3387 d 03:29 ago) – Posting: # 15989
Views: 22,940

Dear Ohlbe,

❝ Well, cough... I your example there is not much difference for AUC, agreed. But Cmax ? A difference of 4 points in the point estimate, …


Actually 5.9%!

❝ … closer to 1 with the lousy method, with 90 % CI of 78.6 - 99.8 % with the lousy method against 71.1 - 96.4 % with the good method... In this specific example I would say that yes, it could have mattered, and made a difference between a failing study and a passing study !


Agreed. I guess the difference would have been smaller if we didn’t stop the LC/MS-MS method after 12 subjects (in the good ol’ days of plausibility reviews). The lousy method was validated and all batches passed. Nowadays such a method likely would not survive the ISR. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
53 visitors (0 registered, 53 guests [including 33 identified bots]).
Forum time: 20:31 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5